Toronto Stock Exchange Symbol: CYT
MONTREAL, July 30 /PRNewswire-FirstCall/ - CryoCath (TSX: CYT), will
hold a conference call to discuss its third quarter 2008 financial results
at 9:00 a.m. (Eastern Time) on Tuesday, August 5, 2008. The call will be
hosted by Mr. Jan Keltjens, President and CEO and Mrs. Ginette Gagne, CFO.
The Company will report its results in a press release to be issued at 7:00
a.m on Tuesday, August 5.
DATE: Tuesday, August 5, 2008
TIME: 9:00 a.m., Eastern Time
DIAL IN NUMBER: 416-644-3427 or 1-866-250-4892
TAPED REPLAY: 416-640-1917 or 1-877-289-8525
REFERENCE NUMBER: 21279395 followed by the number sign
WEBCAST: A live audio webcast of the call will be available
at http://www.cryocath.com. Webcast attendees are welcome
to listen to the conference in real-time or
on-demand at their convenience. The webcast will be
archived for 365 days. Please connect to this
website at least 15 minutes prior to the conference
call to ensure adequate time for any software
download that may be needed to hear the webcast.
A question and answer session will follow, at which time the operator will direct participants as to the correct procedure for submitting questions.
CryoCath - http://www.cryocath.com - is a medical technology company that leads the world in cryotherapy products to treat cardiac arrhythmias. With a priority focus on providing physicians with a complete solution of catheter products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The Company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias.
This press release includes "forward-looking statements" that are subject to risks and uncertainties, including with respect to the timing of regulatory trials and their outcome. For information identifying legislative or regulatory, economic, climatic, currency, technological, competitive and other important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, see CryoCath's annual report available at http://www.sedar.com under the heading Risks and Uncertainties in the Management's Discussion and Analysis section.
|SOURCE CryoCath Technologies Inc.|
Copyright©2008 PR Newswire.
All rights reserved